Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-04-16

FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for tapentadol hydrochloride (generic tapentadol), authorizing its marketing in the Unite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

SUPPL AP for TAPENTADOL (TAPENTADOL HYDROCHLORIDE)